Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Bruker Licenses 3M Patents for Maldi Imaging
Jun 2013
BREMEN, Germany, June 4, 2013 — Bruker Corp. has signed a patent license agreement with 3M Co. enabling Bruker to include 3M innovations relating to matrix-assisted laser desorption ionization (Maldi) mass spectrometry imaging.

The patents are directed to a technique for performing mass spectrometry analysis on proteins in tissue that has been preserved in paraffin. The technology enables researchers to more easily study formalin-fixed, paraffin-embedded (FFPE) tissue for life sciences research and drug development.

Maldi imaging was originally developed to analyze fresh, frozen tissue sections, but the analysis of preserved FFPE tissue sections is becoming increasingly important because of methodological improvements. An antigen-retrieval pretreatment for FFPE tissue is now widely accepted in the Maldi imaging community.

“We hope that this license agreement will accelerate the research in Maldi imaging of FFPE tissue, and enable it to ultimately become a valuable diagnostic tool,” said Dr. Todd Fruchterman, senior vice president of R&D and chief medical officer for 3M Health Care.

For more information, visit: or

3M3M Health CareBiophotonicsBruker Corp.BusinessEuropeFFPEGermanyimagingMaldi imagingmass spectrometry imagingmatrix-assisted laser desorption ionizationspectroscopytissue sampleTodd Fruchtermanlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x We deliver – right to your inbox. Subscribe FREE to our newsletters.